Analysts: CBS Dominates Ratings and 3 More Research Notes to Read Through
CBS (NYSE:CBS): Benchmark Co. raised its price target for CBS to $63 from $50, citing the company’s ratings dominance and expanded repurchase program. The firm keeps a Buy rating on the stock.
Zillow (NASDAQ:Z): Benchmark Co. raised its price target for Zillow to $105 from $75, pointing to the company’s accelerated traffic growth in the second quarter and a clearer path to monetization behind its decision. The firm keeps a Buy rating on the stock.
Mead Johnson (NYSE:MJN): Credit Suisse expects Mead Johnson to benefit from a competitor recall in China and for improved top-line results to offset recent price cuts. The firm upgraded shares to Outperform from Neutral and raised its price target to $90 from $76.
Jazz Pharmaceuticals (NASDAQ:JAZZ): Following Jazz’s report of in-line revenue but lower than expected earnings per share, Cantor notes that the company’s revenue is growing at a nearly a 70 percent clip. The firm thinks the stock can advance further, and it keeps a Buy rating on the shares.